nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—SLC6A4—migraine	0.365	1	CbGaD
Amphetamine—SLC6A4—Amitriptyline—migraine	0.0584	0.145	CbGbCtD
Amphetamine—SLC22A5—Valproic Acid—migraine	0.0558	0.138	CbGbCtD
Amphetamine—SLC6A2—Amitriptyline—migraine	0.0488	0.121	CbGbCtD
Amphetamine—SLC22A5—Verapamil—migraine	0.0486	0.121	CbGbCtD
Amphetamine—SLC6A4—Verapamil—migraine	0.0463	0.115	CbGbCtD
Amphetamine—CYP2A6—Valproic Acid—migraine	0.0424	0.105	CbGbCtD
Amphetamine—DRD2—Amitriptyline—migraine	0.0405	0.101	CbGbCtD
Amphetamine—CYP2D6—Timolol—migraine	0.019	0.0471	CbGbCtD
Amphetamine—CYP2D6—Propranolol—migraine	0.0169	0.042	CbGbCtD
Amphetamine—CYP2D6—Amitriptyline—migraine	0.0146	0.0363	CbGbCtD
Amphetamine—CYP2D6—Verapamil—migraine	0.0116	0.0288	CbGbCtD
Amphetamine—CARTPT—nerve—migraine	0.00575	0.111	CbGeAlD
Amphetamine—SLC6A2—locus ceruleus—migraine	0.00399	0.0771	CbGeAlD
Amphetamine—TAAR1—neck—migraine	0.00323	0.0624	CbGeAlD
Amphetamine—SLC6A2—sympathetic nervous system—migraine	0.00315	0.0609	CbGeAlD
Amphetamine—TAAR1—Amine ligand-binding receptors—HTR1D—migraine	0.00259	0.0416	CbGpPWpGaD
Amphetamine—CARTPT—brainstem—migraine	0.00247	0.0477	CbGeAlD
Amphetamine—TAAR1—Amine ligand-binding receptors—HTR2B—migraine	0.00241	0.0387	CbGpPWpGaD
Amphetamine—SLC6A2—autonomic nervous system—migraine	0.00212	0.0409	CbGeAlD
Amphetamine—Phenacemide—SCN1A—migraine	0.00188	0.624	CrCbGaD
Amphetamine—CARTPT—Circadian rythm related genes—NPS—migraine	0.00158	0.0254	CbGpPWpGaD
Amphetamine—TAAR1—Amine ligand-binding receptors—HTR1B—migraine	0.00157	0.0252	CbGpPWpGaD
Amphetamine—CARTPT—Circadian rythm related genes—SLC6A4—migraine	0.00155	0.0249	CbGpPWpGaD
Amphetamine—SLC18A2—Synaptic Vesicle Pathway—ATP1A2—migraine	0.00153	0.0246	CbGpPWpGaD
Amphetamine—TAAR1—Amine ligand-binding receptors—HTR1A—migraine	0.00151	0.0243	CbGpPWpGaD
Amphetamine—SLC6A3—nerve—migraine	0.00148	0.0285	CbGeAlD
Amphetamine—TAAR1—G alpha (s) signalling events—CALCRL—migraine	0.00147	0.0236	CbGpPWpGaD
Amphetamine—TAAR1—G alpha (s) signalling events—RAMP1—migraine	0.00147	0.0236	CbGpPWpGaD
Amphetamine—TAAR1—Amine ligand-binding receptors—HTR2C—migraine	0.00146	0.0235	CbGpPWpGaD
Amphetamine—CARTPT—head—migraine	0.00136	0.0263	CbGeAlD
Amphetamine—CARTPT—Circadian rythm related genes—HTR7—migraine	0.00136	0.0218	CbGpPWpGaD
Amphetamine—SLC22A3—Synaptic Vesicle Pathway—ATP1A2—migraine	0.00132	0.0213	CbGpPWpGaD
Amphetamine—CARTPT—nervous system—migraine	0.00129	0.025	CbGeAlD
Amphetamine—TAAR1—nervous system—migraine	0.00129	0.025	CbGeAlD
Amphetamine—MAOB—nerve—migraine	0.00129	0.0249	CbGeAlD
Amphetamine—TAAR1—Amine ligand-binding receptors—HTR7—migraine	0.00128	0.0205	CbGpPWpGaD
Amphetamine—CARTPT—central nervous system—migraine	0.00124	0.024	CbGeAlD
Amphetamine—TAAR1—central nervous system—migraine	0.00124	0.024	CbGeAlD
Amphetamine—CARTPT—cerebellum—migraine	0.00122	0.0235	CbGeAlD
Amphetamine—SLC6A4—Synaptic Vesicle Pathway—ATP1A2—migraine	0.0012	0.0192	CbGpPWpGaD
Amphetamine—SLC6A2—nerve—migraine	0.00119	0.023	CbGeAlD
Amphetamine—SLC18A2—Synaptic Vesicle Pathway—CACNA1A—migraine	0.00111	0.0178	CbGpPWpGaD
Amphetamine—DRD2—nerve—migraine	0.00109	0.021	CbGeAlD
Amphetamine—CARTPT—brain—migraine	0.000988	0.0191	CbGeAlD
Amphetamine—SLC22A3—Synaptic Vesicle Pathway—CACNA1A—migraine	0.000956	0.0154	CbGpPWpGaD
Amphetamine—TAAR1—Amine ligand-binding receptors—HTR2A—migraine	0.000895	0.0144	CbGpPWpGaD
Amphetamine—SLC6A4—Synaptic Vesicle Pathway—CACNA1A—migraine	0.000865	0.0139	CbGpPWpGaD
Amphetamine—SLC18A2—brainstem—migraine	0.000839	0.0162	CbGeAlD
Amphetamine—DRD2—Monoamine GPCRs—HTR1D—migraine	0.000719	0.0116	CbGpPWpGaD
Amphetamine—SLC22A3—trigeminal ganglion—migraine	0.000675	0.013	CbGeAlD
Amphetamine—DRD2—Monoamine GPCRs—HTR2B—migraine	0.000668	0.0107	CbGpPWpGaD
Amphetamine—SLC6A3—brainstem—migraine	0.000634	0.0123	CbGeAlD
Amphetamine—MAOB—trigeminal ganglion—migraine	0.000624	0.0121	CbGeAlD
Amphetamine—TAAR1—G alpha (s) signalling events—NPS—migraine	0.000614	0.00987	CbGpPWpGaD
Amphetamine—DRD2—Amine ligand-binding receptors—HTR1D—migraine	0.000604	0.00971	CbGpPWpGaD
Amphetamine—SLC18A2—Synaptic Vesicle Pathway—SLC6A4—migraine	0.000597	0.00959	CbGpPWpGaD
Amphetamine—SLC6A2—Monoamine Transport—SLC6A4—migraine	0.000583	0.00937	CbGpPWpGaD
Amphetamine—SLC18A2—Neuronal System—KCNK18—migraine	0.000581	0.00934	CbGpPWpGaD
Amphetamine—SLC6A4—brainstem—migraine	0.000581	0.0112	CbGeAlD
Amphetamine—TAAR1—G alpha (s) signalling events—CALCA—migraine	0.000564	0.00906	CbGpPWpGaD
Amphetamine—DRD2—Amine ligand-binding receptors—HTR2B—migraine	0.000562	0.00903	CbGpPWpGaD
Amphetamine—MAOB—brainstem—migraine	0.000553	0.0107	CbGeAlD
Amphetamine—TAAR1—GPCR ligand binding—RAMP1—migraine	0.000534	0.00858	CbGpPWpGaD
Amphetamine—TAAR1—GPCR ligand binding—CALCRL—migraine	0.000534	0.00858	CbGpPWpGaD
Amphetamine—TAAR1—G alpha (s) signalling events—HTR7—migraine	0.000527	0.00847	CbGpPWpGaD
Amphetamine—SLC6A3—Monoamine Transport—SLC6A4—migraine	0.000517	0.0083	CbGpPWpGaD
Amphetamine—SLC22A3—Synaptic Vesicle Pathway—SLC6A4—migraine	0.000516	0.0083	CbGpPWpGaD
Amphetamine—SLC6A2—brainstem—migraine	0.000512	0.00989	CbGeAlD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.00051	0.00819	CbGpPWpGaD
Amphetamine—SLC22A5—trigeminal ganglion—migraine	0.000491	0.00948	CbGeAlD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000489	0.00786	CbGpPWpGaD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000474	0.00761	CbGpPWpGaD
Amphetamine—DRD2—brainstem—migraine	0.000466	0.00901	CbGeAlD
Amphetamine—SLC18A2—head—migraine	0.000463	0.00895	CbGeAlD
Amphetamine—MAOB—cardiovascular system—migraine	0.000451	0.00871	CbGeAlD
Amphetamine—SLC18A2—nervous system—migraine	0.000439	0.00849	CbGeAlD
Amphetamine—DRD2—Monoamine GPCRs—HTR1B—migraine	0.000435	0.007	CbGpPWpGaD
Amphetamine—Insomnia—Amitriptyline—migraine	0.000434	0.00377	CcSEcCtD
Amphetamine—Euphoric mood—Topiramate—migraine	0.000428	0.00372	CcSEcCtD
Amphetamine—Somnolence—Amitriptyline—migraine	0.000426	0.00371	CcSEcCtD
Amphetamine—Disturbance in sexual arousal—Gabapentin—migraine	0.000426	0.00371	CcSEcCtD
Amphetamine—SLC18A2—central nervous system—migraine	0.000423	0.00817	CbGeAlD
Amphetamine—Affect lability—Gabapentin—migraine	0.000423	0.00368	CcSEcCtD
Amphetamine—Dyspepsia—Amitriptyline—migraine	0.000422	0.00367	CcSEcCtD
Amphetamine—Abdominal pain upper—Timolol—migraine	0.000421	0.00366	CcSEcCtD
Amphetamine—Psychotic disorder—Gabapentin—migraine	0.000419	0.00365	CcSEcCtD
Amphetamine—DRD2—Monoamine GPCRs—HTR1A—migraine	0.000419	0.00674	CbGpPWpGaD
Amphetamine—Decreased appetite—Amitriptyline—migraine	0.000417	0.00363	CcSEcCtD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—HTR3A—migraine	0.000416	0.00669	CbGpPWpGaD
Amphetamine—Convulsion—Propranolol—migraine	0.000414	0.00361	CcSEcCtD
Amphetamine—SLC18A2—cerebellum—migraine	0.000413	0.00799	CbGeAlD
Amphetamine—Fatigue—Amitriptyline—migraine	0.000413	0.0036	CcSEcCtD
Amphetamine—Tremor—Verapamil—migraine	0.000412	0.00359	CcSEcCtD
Amphetamine—Constipation—Amitriptyline—migraine	0.00041	0.00357	CcSEcCtD
Amphetamine—Irritability—Gabapentin—migraine	0.00041	0.00357	CcSEcCtD
Amphetamine—Photosensitivity reaction—Valproic Acid—migraine	0.000409	0.00356	CcSEcCtD
Amphetamine—Mood swings—Gabapentin—migraine	0.000407	0.00354	CcSEcCtD
Amphetamine—Weight decreased—Valproic Acid—migraine	0.000405	0.00352	CcSEcCtD
Amphetamine—DRD2—Monoamine GPCRs—HTR2C—migraine	0.000405	0.00651	CbGpPWpGaD
Amphetamine—Agitation—Verapamil—migraine	0.000404	0.00352	CcSEcCtD
Amphetamine—Angioedema—Verapamil—migraine	0.000402	0.0035	CcSEcCtD
Amphetamine—Depression—Valproic Acid—migraine	0.000398	0.00346	CcSEcCtD
Amphetamine—Stevens-Johnson syndrome—Valproic Acid—migraine	0.000396	0.00344	CcSEcCtD
Amphetamine—Anaphylactic shock—Propranolol—migraine	0.00039	0.0034	CcSEcCtD
Amphetamine—Libido decreased—Topiramate—migraine	0.00039	0.00339	CcSEcCtD
Amphetamine—Palpitations—Verapamil—migraine	0.000389	0.00338	CcSEcCtD
Amphetamine—Urinary tract infection—Valproic Acid—migraine	0.000388	0.00338	CcSEcCtD
Amphetamine—TAAR1—GPCR ligand binding—HTR1D—migraine	0.000388	0.00624	CbGpPWpGaD
Amphetamine—Infection—Propranolol—migraine	0.000388	0.00337	CcSEcCtD
Amphetamine—Sweating—Valproic Acid—migraine	0.000383	0.00333	CcSEcCtD
Amphetamine—Convulsion—Verapamil—migraine	0.000381	0.00332	CcSEcCtD
Amphetamine—Urticaria—Amitriptyline—migraine	0.000381	0.00331	CcSEcCtD
Amphetamine—Hypertension—Verapamil—migraine	0.00038	0.00331	CcSEcCtD
Amphetamine—Body temperature increased—Amitriptyline—migraine	0.000379	0.0033	CcSEcCtD
Amphetamine—Chest pain—Verapamil—migraine	0.000375	0.00326	CcSEcCtD
Amphetamine—SLC18A2—Transmission across Chemical Synapses—CACNA1A—migraine	0.000371	0.00595	CbGpPWpGaD
Amphetamine—CYP2A6—cerebellum—migraine	0.000369	0.00713	CbGeAlD
Amphetamine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—FOS—migraine	0.000369	0.00593	CbGpPWpGaD
Amphetamine—Erectile dysfunction—Timolol—migraine	0.000367	0.00319	CcSEcCtD
Amphetamine—Dry mouth—Verapamil—migraine	0.000366	0.00319	CcSEcCtD
Amphetamine—DRD2—Amine ligand-binding receptors—HTR1B—migraine	0.000366	0.00588	CbGpPWpGaD
Amphetamine—TAAR1—GPCR ligand binding—HTR2B—migraine	0.000361	0.0058	CbGpPWpGaD
Amphetamine—Weight decreased—Timolol—migraine	0.000361	0.00314	CcSEcCtD
Amphetamine—Anaphylactic shock—Verapamil—migraine	0.000359	0.00312	CcSEcCtD
Amphetamine—Disturbance in sexual arousal—Topiramate—migraine	0.000358	0.00312	CcSEcCtD
Amphetamine—Infection—Verapamil—migraine	0.000357	0.0031	CcSEcCtD
Amphetamine—Affect lability—Topiramate—migraine	0.000356	0.00309	CcSEcCtD
Amphetamine—DRD2—Monoamine GPCRs—HTR7—migraine	0.000355	0.0057	CbGpPWpGaD
Amphetamine—Depression—Timolol—migraine	0.000354	0.00308	CcSEcCtD
Amphetamine—Insomnia—Propranolol—migraine	0.000353	0.00307	CcSEcCtD
Amphetamine—Psychotic disorder—Topiramate—migraine	0.000353	0.00307	CcSEcCtD
Amphetamine—DRD2—Amine ligand-binding receptors—HTR1A—migraine	0.000352	0.00566	CbGpPWpGaD
Amphetamine—Tachycardia—Verapamil—migraine	0.000351	0.00305	CcSEcCtD
Amphetamine—SLC6A3—head—migraine	0.000351	0.00677	CbGeAlD
Amphetamine—Pseudoephedrine—TNF—migraine	0.000348	0.115	CrCbGaD
Amphetamine—Dyspnoea—Propranolol—migraine	0.000348	0.00303	CcSEcCtD
Amphetamine—Hyperhidrosis—Verapamil—migraine	0.000347	0.00302	CcSEcCtD
Amphetamine—Somnolence—Propranolol—migraine	0.000347	0.00302	CcSEcCtD
Amphetamine—SLC6A3—Neuronal System—KCNK18—migraine	0.000347	0.00557	CbGpPWpGaD
Amphetamine—Irritability—Topiramate—migraine	0.000345	0.003	CcSEcCtD
Amphetamine—Asthenia—Amitriptyline—migraine	0.000344	0.00299	CcSEcCtD
Amphetamine—Dyspepsia—Propranolol—migraine	0.000344	0.00299	CcSEcCtD
Amphetamine—Mood swings—Topiramate—migraine	0.000342	0.00298	CcSEcCtD
Amphetamine—Erectile dysfunction—Gabapentin—migraine	0.000342	0.00297	CcSEcCtD
Amphetamine—Sweating—Timolol—migraine	0.000341	0.00296	CcSEcCtD
Amphetamine—DRD2—Amine ligand-binding receptors—HTR2C—migraine	0.00034	0.00547	CbGpPWpGaD
Amphetamine—Decreased appetite—Propranolol—migraine	0.000339	0.00295	CcSEcCtD
Amphetamine—Erythema multiforme—Valproic Acid—migraine	0.000339	0.00295	CcSEcCtD
Amphetamine—Photosensitivity reaction—Gabapentin—migraine	0.000339	0.00295	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Propranolol—migraine	0.000337	0.00293	CcSEcCtD
Amphetamine—Fatigue—Propranolol—migraine	0.000337	0.00293	CcSEcCtD
Amphetamine—Weight decreased—Gabapentin—migraine	0.000336	0.00292	CcSEcCtD
Amphetamine—SLC18A2—brain—migraine	0.000336	0.00649	CbGeAlD
Amphetamine—Constipation—Propranolol—migraine	0.000334	0.0029	CcSEcCtD
Amphetamine—SLC6A3—nervous system—migraine	0.000332	0.00642	CbGeAlD
Amphetamine—Depression—Gabapentin—migraine	0.00033	0.00287	CcSEcCtD
Amphetamine—Abdominal pain upper—Topiramate—migraine	0.00033	0.00287	CcSEcCtD
Amphetamine—SLC22A3—head—migraine	0.00033	0.00638	CbGeAlD
Amphetamine—Stevens-Johnson syndrome—Gabapentin—migraine	0.000328	0.00285	CcSEcCtD
Amphetamine—Diarrhoea—Amitriptyline—migraine	0.000328	0.00285	CcSEcCtD
Amphetamine—Acute coronary syndrome—Gabapentin—migraine	0.000326	0.00284	CcSEcCtD
Amphetamine—Toxic epidermal necrolysis—Topiramate—migraine	0.000325	0.00283	CcSEcCtD
Amphetamine—Insomnia—Verapamil—migraine	0.000325	0.00283	CcSEcCtD
Amphetamine—Myocardial infarction—Gabapentin—migraine	0.000324	0.00282	CcSEcCtD
Amphetamine—Urinary tract infection—Gabapentin—migraine	0.000322	0.0028	CcSEcCtD
Amphetamine—SLC6A4—head—migraine	0.000321	0.00621	CbGeAlD
Amphetamine—Dyspnoea—Verapamil—migraine	0.00032	0.00279	CcSEcCtD
Amphetamine—SLC6A3—central nervous system—migraine	0.00032	0.00618	CbGeAlD
Amphetamine—Somnolence—Verapamil—migraine	0.000319	0.00278	CcSEcCtD
Amphetamine—Gastrointestinal pain—Propranolol—migraine	0.000319	0.00278	CcSEcCtD
Amphetamine—Sweating—Gabapentin—migraine	0.000317	0.00276	CcSEcCtD
Amphetamine—Dizziness—Amitriptyline—migraine	0.000317	0.00276	CcSEcCtD
Amphetamine—Dyspepsia—Verapamil—migraine	0.000316	0.00275	CcSEcCtD
Amphetamine—SLC22A3—nervous system—migraine	0.000313	0.00604	CbGeAlD
Amphetamine—SLC6A3—cerebellum—migraine	0.000313	0.00604	CbGeAlD
Amphetamine—Urticaria—Propranolol—migraine	0.00031	0.0027	CcSEcCtD
Amphetamine—Fatigue—Verapamil—migraine	0.00031	0.00269	CcSEcCtD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000309	0.00496	CbGpPWpGaD
Amphetamine—Abdominal pain—Propranolol—migraine	0.000309	0.00269	CcSEcCtD
Amphetamine—Body temperature increased—Propranolol—migraine	0.000309	0.00269	CcSEcCtD
Amphetamine—Constipation—Verapamil—migraine	0.000307	0.00267	CcSEcCtD
Amphetamine—Tension—Valproic Acid—migraine	0.000306	0.00266	CcSEcCtD
Amphetamine—MAOB—head—migraine	0.000305	0.0059	CbGeAlD
Amphetamine—Vomiting—Amitriptyline—migraine	0.000305	0.00265	CcSEcCtD
Amphetamine—SLC6A4—nervous system—migraine	0.000305	0.00588	CbGeAlD
Amphetamine—Nervousness—Valproic Acid—migraine	0.000303	0.00264	CcSEcCtD
Amphetamine—Rash—Amitriptyline—migraine	0.000302	0.00263	CcSEcCtD
Amphetamine—Dermatitis—Amitriptyline—migraine	0.000302	0.00263	CcSEcCtD
Amphetamine—TAAR1—GPCR downstream signaling—CALCRL—migraine	0.000302	0.00485	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—RAMP1—migraine	0.000302	0.00485	CbGpPWpGaD
Amphetamine—SLC22A3—central nervous system—migraine	0.000301	0.00582	CbGeAlD
Amphetamine—Headache—Amitriptyline—migraine	0.0003	0.00261	CcSEcCtD
Amphetamine—CYP2A6—brain—migraine	0.0003	0.00579	CbGeAlD
Amphetamine—DRD2—Amine ligand-binding receptors—HTR7—migraine	0.000298	0.00479	CbGpPWpGaD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000297	0.00478	CbGpPWpGaD
Amphetamine—Phentermine—SLC6A4—migraine	0.000296	0.098	CrCbGaD
Amphetamine—SLC6A4—central nervous system—migraine	0.000293	0.00566	CbGeAlD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000293	0.0047	CbGpPWpGaD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000293	0.0047	CbGpPWpGaD
Amphetamine—Tremor—Valproic Acid—migraine	0.000292	0.00254	CcSEcCtD
Amphetamine—MAOB—nervous system—migraine	0.00029	0.00559	CbGeAlD
Amphetamine—Hypersensitivity—Propranolol—migraine	0.000288	0.0025	CcSEcCtD
Amphetamine—Erectile dysfunction—Topiramate—migraine	0.000288	0.0025	CcSEcCtD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000287	0.00461	CbGpPWpGaD
Amphetamine—Agitation—Valproic Acid—migraine	0.000287	0.00249	CcSEcCtD
Amphetamine—Urticaria—Verapamil—migraine	0.000285	0.00248	CcSEcCtD
Amphetamine—Angioedema—Valproic Acid—migraine	0.000285	0.00248	CcSEcCtD
Amphetamine—Photosensitivity reaction—Topiramate—migraine	0.000285	0.00248	CcSEcCtD
Amphetamine—Nausea—Amitriptyline—migraine	0.000285	0.00248	CcSEcCtD
Amphetamine—SLC18A2—Neuronal System—CACNA1A—migraine	0.000284	0.00456	CbGpPWpGaD
Amphetamine—SLC6A2—head—migraine	0.000283	0.00546	CbGeAlD
Amphetamine—Weight decreased—Topiramate—migraine	0.000283	0.00246	CcSEcCtD
Amphetamine—Erythema multiforme—Gabapentin—migraine	0.000281	0.00244	CcSEcCtD
Amphetamine—Pseudoephedrine—SLC6A4—migraine	0.00028	0.0929	CrCbGaD
Amphetamine—CYP2D6—brainstem—migraine	0.00028	0.00541	CbGeAlD
Amphetamine—Asthenia—Propranolol—migraine	0.00028	0.00244	CcSEcCtD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000279	0.00449	CbGpPWpGaD
Amphetamine—MAOB—central nervous system—migraine	0.000279	0.00539	CbGeAlD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—TRPM8—migraine	0.000279	0.00448	CbGpPWpGaD
Amphetamine—Depression—Topiramate—migraine	0.000278	0.00242	CcSEcCtD
Amphetamine—Stevens-Johnson syndrome—Topiramate—migraine	0.000276	0.0024	CcSEcCtD
Amphetamine—Palpitations—Valproic Acid—migraine	0.000276	0.0024	CcSEcCtD
Amphetamine—TAAR1—Signaling by GPCR—RAMP1—migraine	0.000274	0.0044	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—CALCRL—migraine	0.000274	0.0044	CbGpPWpGaD
Amphetamine—Tension—Timolol—migraine	0.000273	0.00237	CcSEcCtD
Amphetamine—MAOB—cerebellum—migraine	0.000272	0.00526	CbGeAlD
Amphetamine—Urinary tract infection—Topiramate—migraine	0.000271	0.00235	CcSEcCtD
Amphetamine—Nervousness—Timolol—migraine	0.00027	0.00235	CcSEcCtD
Amphetamine—Hypertension—Valproic Acid—migraine	0.000269	0.00234	CcSEcCtD
Amphetamine—SLC6A2—nervous system—migraine	0.000268	0.00518	CbGeAlD
Amphetamine—Diarrhoea—Propranolol—migraine	0.000267	0.00232	CcSEcCtD
Amphetamine—Chest pain—Valproic Acid—migraine	0.000266	0.00231	CcSEcCtD
Amphetamine—Anxiety—Valproic Acid—migraine	0.000265	0.0023	CcSEcCtD
Amphetamine—Hypersensitivity—Verapamil—migraine	0.000265	0.0023	CcSEcCtD
Amphetamine—Dry mouth—Valproic Acid—migraine	0.00026	0.00226	CcSEcCtD
Amphetamine—Dizziness—Propranolol—migraine	0.000258	0.00225	CcSEcCtD
Amphetamine—SLC6A2—central nervous system—migraine	0.000258	0.00499	CbGeAlD
Amphetamine—CYP2A6—Fluoropyrimidine Activity—MTHFR—migraine	0.000258	0.00415	CbGpPWpGaD
Amphetamine—Asthenia—Verapamil—migraine	0.000258	0.00224	CcSEcCtD
Amphetamine—DRD2—head—migraine	0.000258	0.00498	CbGeAlD
Amphetamine—Anaphylactic shock—Valproic Acid—migraine	0.000255	0.00222	CcSEcCtD
Amphetamine—SLC6A3—brain—migraine	0.000254	0.00491	CbGeAlD
Amphetamine—Tension—Gabapentin—migraine	0.000254	0.00221	CcSEcCtD
Amphetamine—Angioedema—Timolol—migraine	0.000254	0.00221	CcSEcCtD
Amphetamine—Infection—Valproic Acid—migraine	0.000253	0.0022	CcSEcCtD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000251	0.00404	CbGpPWpGaD
Amphetamine—Nervousness—Gabapentin—migraine	0.000251	0.00219	CcSEcCtD
Amphetamine—Tachycardia—Valproic Acid—migraine	0.000249	0.00216	CcSEcCtD
Amphetamine—DRD2—Monoamine GPCRs—HTR2A—migraine	0.000248	0.00399	CbGpPWpGaD
Amphetamine—Vomiting—Propranolol—migraine	0.000248	0.00216	CcSEcCtD
Amphetamine—Hyperhidrosis—Valproic Acid—migraine	0.000246	0.00214	CcSEcCtD
Amphetamine—Rash—Propranolol—migraine	0.000246	0.00214	CcSEcCtD
Amphetamine—Dermatitis—Propranolol—migraine	0.000246	0.00214	CcSEcCtD
Amphetamine—Diarrhoea—Verapamil—migraine	0.000246	0.00214	CcSEcCtD
Amphetamine—Palpitations—Timolol—migraine	0.000245	0.00214	CcSEcCtD
Amphetamine—DRD2—nervous system—migraine	0.000244	0.00472	CbGeAlD
Amphetamine—Anorexia—Valproic Acid—migraine	0.000243	0.00211	CcSEcCtD
Amphetamine—Tremor—Gabapentin—migraine	0.000242	0.00211	CcSEcCtD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—TRPM8—migraine	0.000241	0.00387	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—TRPM8—migraine	0.00024	0.00386	CbGpPWpGaD
Amphetamine—Hypertension—Timolol—migraine	0.00024	0.00209	CcSEcCtD
Amphetamine—SLC22A3—brain—migraine	0.000239	0.00462	CbGeAlD
Amphetamine—Agitation—Gabapentin—migraine	0.000238	0.00207	CcSEcCtD
Amphetamine—Dizziness—Verapamil—migraine	0.000237	0.00207	CcSEcCtD
Amphetamine—Chest pain—Timolol—migraine	0.000236	0.00206	CcSEcCtD
Amphetamine—Erythema multiforme—Topiramate—migraine	0.000236	0.00206	CcSEcCtD
Amphetamine—Angioedema—Gabapentin—migraine	0.000236	0.00206	CcSEcCtD
Amphetamine—Anxiety—Timolol—migraine	0.000236	0.00205	CcSEcCtD
Amphetamine—DRD2—central nervous system—migraine	0.000235	0.00454	CbGeAlD
Amphetamine—TAAR1—GPCR ligand binding—HTR1B—migraine	0.000235	0.00378	CbGpPWpGaD
Amphetamine—SLC6A4—brain—migraine	0.000233	0.0045	CbGeAlD
Amphetamine—Nausea—Propranolol—migraine	0.000232	0.00202	CcSEcCtD
Amphetamine—Dry mouth—Timolol—migraine	0.000231	0.00201	CcSEcCtD
Amphetamine—Insomnia—Valproic Acid—migraine	0.00023	0.002	CcSEcCtD
Amphetamine—DRD2—cerebellum—migraine	0.00023	0.00444	CbGeAlD
Amphetamine—Palpitations—Gabapentin—migraine	0.000229	0.00199	CcSEcCtD
Amphetamine—Vomiting—Verapamil—migraine	0.000228	0.00199	CcSEcCtD
Amphetamine—Dyspnoea—Valproic Acid—migraine	0.000227	0.00198	CcSEcCtD
Amphetamine—Anaphylactic shock—Timolol—migraine	0.000227	0.00197	CcSEcCtD
Amphetamine—Rash—Verapamil—migraine	0.000226	0.00197	CcSEcCtD
Amphetamine—Somnolence—Valproic Acid—migraine	0.000226	0.00197	CcSEcCtD
Amphetamine—TAAR1—GPCR ligand binding—HTR1A—migraine	0.000226	0.00364	CbGpPWpGaD
Amphetamine—Dermatitis—Verapamil—migraine	0.000226	0.00197	CcSEcCtD
Amphetamine—Infection—Timolol—migraine	0.000225	0.00196	CcSEcCtD
Amphetamine—Headache—Verapamil—migraine	0.000225	0.00196	CcSEcCtD
Amphetamine—Dyspepsia—Valproic Acid—migraine	0.000224	0.00195	CcSEcCtD
Amphetamine—Convulsion—Gabapentin—migraine	0.000224	0.00195	CcSEcCtD
Amphetamine—Hypertension—Gabapentin—migraine	0.000223	0.00194	CcSEcCtD
Amphetamine—TAAR1—GPCR ligand binding—NPS—migraine	0.000223	0.00358	CbGpPWpGaD
Amphetamine—TAAR1—GPCR ligand binding—TAC1—migraine	0.000223	0.00358	CbGpPWpGaD
Amphetamine—Decreased appetite—Valproic Acid—migraine	0.000221	0.00193	CcSEcCtD
Amphetamine—MAOB—brain—migraine	0.000221	0.00428	CbGeAlD
Amphetamine—SLC6A3—Transmission across Chemical Synapses—CACNA1A—migraine	0.000221	0.00355	CbGpPWpGaD
Amphetamine—Chest pain—Gabapentin—migraine	0.00022	0.00192	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Valproic Acid—migraine	0.00022	0.00191	CcSEcCtD
Amphetamine—Fatigue—Valproic Acid—migraine	0.00022	0.00191	CcSEcCtD
Amphetamine—Anxiety—Gabapentin—migraine	0.000219	0.00191	CcSEcCtD
Amphetamine—TAAR1—GPCR downstream signaling—HTR1D—migraine	0.000219	0.00352	CbGpPWpGaD
Amphetamine—Hyperhidrosis—Timolol—migraine	0.000219	0.00191	CcSEcCtD
Amphetamine—TAAR1—GPCR ligand binding—HTR2C—migraine	0.000219	0.00351	CbGpPWpGaD
Amphetamine—Constipation—Valproic Acid—migraine	0.000218	0.00189	CcSEcCtD
Amphetamine—Anorexia—Timolol—migraine	0.000216	0.00188	CcSEcCtD
Amphetamine—Dry mouth—Gabapentin—migraine	0.000215	0.00187	CcSEcCtD
Amphetamine—SLC22A5—cerebellum—migraine	0.000214	0.00414	CbGeAlD
Amphetamine—Tension—Topiramate—migraine	0.000214	0.00186	CcSEcCtD
Amphetamine—Nausea—Verapamil—migraine	0.000213	0.00186	CcSEcCtD
Amphetamine—TAAR1—GPCR ligand binding—EDNRA—migraine	0.000213	0.00342	CbGpPWpGaD
Amphetamine—Nervousness—Topiramate—migraine	0.000211	0.00184	CcSEcCtD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—ATP1A3—migraine	0.000211	0.00339	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—ATP1A2—migraine	0.000211	0.00339	CbGpPWpGaD
Amphetamine—Anaphylactic shock—Gabapentin—migraine	0.000211	0.00184	CcSEcCtD
Amphetamine—Methamphetamine—SLC6A4—migraine	0.000211	0.0698	CrCbGaD
Amphetamine—Infection—Gabapentin—migraine	0.00021	0.00182	CcSEcCtD
Amphetamine—DRD2—Amine ligand-binding receptors—HTR2A—migraine	0.000209	0.00336	CbGpPWpGaD
Amphetamine—Gastrointestinal pain—Valproic Acid—migraine	0.000208	0.00181	CcSEcCtD
Amphetamine—Tachycardia—Gabapentin—migraine	0.000206	0.00179	CcSEcCtD
Amphetamine—Insomnia—Timolol—migraine	0.000205	0.00178	CcSEcCtD
Amphetamine—SLC6A2—brain—migraine	0.000205	0.00396	CbGeAlD
Amphetamine—TAAR1—GPCR ligand binding—CALCA—migraine	0.000205	0.00329	CbGpPWpGaD
Amphetamine—Hyperhidrosis—Gabapentin—migraine	0.000204	0.00178	CcSEcCtD
Amphetamine—Tremor—Topiramate—migraine	0.000204	0.00177	CcSEcCtD
Amphetamine—TAAR1—GPCR downstream signaling—HTR2B—migraine	0.000204	0.00328	CbGpPWpGaD
Amphetamine—Urticaria—Valproic Acid—migraine	0.000202	0.00176	CcSEcCtD
Amphetamine—Dyspnoea—Timolol—migraine	0.000202	0.00176	CcSEcCtD
Amphetamine—Somnolence—Timolol—migraine	0.000202	0.00175	CcSEcCtD
Amphetamine—Body temperature increased—Valproic Acid—migraine	0.000201	0.00175	CcSEcCtD
Amphetamine—Abdominal pain—Valproic Acid—migraine	0.000201	0.00175	CcSEcCtD
Amphetamine—Anorexia—Gabapentin—migraine	0.000201	0.00175	CcSEcCtD
Amphetamine—Agitation—Topiramate—migraine	0.0002	0.00174	CcSEcCtD
Amphetamine—Dyspepsia—Timolol—migraine	0.0002	0.00174	CcSEcCtD
Amphetamine—TAAR1—Signaling by GPCR—HTR1D—migraine	0.000199	0.0032	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—HTR1A—migraine	0.000198	0.00318	CbGpPWpGaD
Amphetamine—Decreased appetite—Timolol—migraine	0.000197	0.00171	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Timolol—migraine	0.000196	0.0017	CcSEcCtD
Amphetamine—Fatigue—Timolol—migraine	0.000195	0.0017	CcSEcCtD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—TAC1—migraine	0.000195	0.00313	CbGpPWpGaD
Amphetamine—Palpitations—Topiramate—migraine	0.000192	0.00167	CcSEcCtD
Amphetamine—TAAR1—GPCR ligand binding—HTR7—migraine	0.000191	0.00308	CbGpPWpGaD
Amphetamine—Insomnia—Gabapentin—migraine	0.000191	0.00166	CcSEcCtD
Amphetamine—Convulsion—Topiramate—migraine	0.000189	0.00164	CcSEcCtD
Amphetamine—Dyspnoea—Gabapentin—migraine	0.000188	0.00164	CcSEcCtD
Amphetamine—Hypertension—Topiramate—migraine	0.000188	0.00163	CcSEcCtD
Amphetamine—Somnolence—Gabapentin—migraine	0.000188	0.00163	CcSEcCtD
Amphetamine—Hypersensitivity—Valproic Acid—migraine	0.000188	0.00163	CcSEcCtD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—TRPM8—migraine	0.000187	0.00301	CbGpPWpGaD
Amphetamine—DRD2—brain—migraine	0.000187	0.00361	CbGeAlD
Amphetamine—Dyspepsia—Gabapentin—migraine	0.000186	0.00162	CcSEcCtD
Amphetamine—Gastrointestinal pain—Timolol—migraine	0.000185	0.00161	CcSEcCtD
Amphetamine—Chest pain—Topiramate—migraine	0.000185	0.00161	CcSEcCtD
Amphetamine—TAAR1—Signaling by GPCR—HTR2B—migraine	0.000185	0.00298	CbGpPWpGaD
Amphetamine—Anxiety—Topiramate—migraine	0.000185	0.00161	CcSEcCtD
Amphetamine—Decreased appetite—Gabapentin—migraine	0.000184	0.0016	CcSEcCtD
Amphetamine—Asthenia—Valproic Acid—migraine	0.000183	0.00159	CcSEcCtD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—ATP1A3—migraine	0.000183	0.00293	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—ATP1A2—migraine	0.000183	0.00293	CbGpPWpGaD
Amphetamine—Gastrointestinal disorder—Gabapentin—migraine	0.000182	0.00159	CcSEcCtD
Amphetamine—Fatigue—Gabapentin—migraine	0.000182	0.00158	CcSEcCtD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—ATP1A3—migraine	0.000182	0.00292	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—ATP1A2—migraine	0.000182	0.00292	CbGpPWpGaD
Amphetamine—Dry mouth—Topiramate—migraine	0.000181	0.00158	CcSEcCtD
Amphetamine—Constipation—Gabapentin—migraine	0.000181	0.00157	CcSEcCtD
Amphetamine—Urticaria—Timolol—migraine	0.00018	0.00157	CcSEcCtD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—HTR3A—migraine	0.00018	0.00289	CbGpPWpGaD
Amphetamine—Body temperature increased—Timolol—migraine	0.000179	0.00156	CcSEcCtD
Amphetamine—Abdominal pain—Timolol—migraine	0.000179	0.00156	CcSEcCtD
Amphetamine—SLC6A4—Monoamine Transport—TNF—migraine	0.000179	0.00288	CbGpPWpGaD
Amphetamine—Infection—Topiramate—migraine	0.000176	0.00154	CcSEcCtD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000176	0.00283	CbGpPWpGaD
Amphetamine—Diarrhoea—Valproic Acid—migraine	0.000174	0.00152	CcSEcCtD
Amphetamine—SLC22A5—brain—migraine	0.000174	0.00336	CbGeAlD
Amphetamine—Tachycardia—Topiramate—migraine	0.000173	0.00151	CcSEcCtD
Amphetamine—SLC6A2—NRF2 pathway—SLC6A4—migraine	0.000173	0.00278	CbGpPWpGaD
Amphetamine—Gastrointestinal pain—Gabapentin—migraine	0.000173	0.0015	CcSEcCtD
Amphetamine—Hyperhidrosis—Topiramate—migraine	0.000172	0.00149	CcSEcCtD
Amphetamine—Anorexia—Topiramate—migraine	0.000169	0.00147	CcSEcCtD
Amphetamine—SLC6A3—Neuronal System—CACNA1A—migraine	0.000169	0.00272	CbGpPWpGaD
Amphetamine—Dizziness—Valproic Acid—migraine	0.000168	0.00146	CcSEcCtD
Amphetamine—Urticaria—Gabapentin—migraine	0.000168	0.00146	CcSEcCtD
Amphetamine—Hypersensitivity—Timolol—migraine	0.000167	0.00145	CcSEcCtD
Amphetamine—Abdominal pain—Gabapentin—migraine	0.000167	0.00145	CcSEcCtD
Amphetamine—Body temperature increased—Gabapentin—migraine	0.000167	0.00145	CcSEcCtD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—TRPM8—migraine	0.000166	0.00267	CbGpPWpGaD
Amphetamine—Asthenia—Timolol—migraine	0.000163	0.00141	CcSEcCtD
Amphetamine—Vomiting—Valproic Acid—migraine	0.000162	0.00141	CcSEcCtD
Amphetamine—TAAR1—Signaling Pathways—RAMP1—migraine	0.000162	0.0026	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CALCRL—migraine	0.000162	0.0026	CbGpPWpGaD
Amphetamine—Insomnia—Topiramate—migraine	0.000161	0.0014	CcSEcCtD
Amphetamine—Rash—Valproic Acid—migraine	0.000161	0.0014	CcSEcCtD
Amphetamine—Dermatitis—Valproic Acid—migraine	0.00016	0.0014	CcSEcCtD
Amphetamine—Headache—Valproic Acid—migraine	0.00016	0.00139	CcSEcCtD
Amphetamine—SLC6A4—Circadian rythm related genes—NPS—migraine	0.000159	0.00256	CbGpPWpGaD
Amphetamine—Dyspnoea—Topiramate—migraine	0.000158	0.00138	CcSEcCtD
Amphetamine—Somnolence—Topiramate—migraine	0.000158	0.00137	CcSEcCtD
Amphetamine—Dyspepsia—Topiramate—migraine	0.000156	0.00136	CcSEcCtD
Amphetamine—Hypersensitivity—Gabapentin—migraine	0.000156	0.00135	CcSEcCtD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—HTR3A—migraine	0.000155	0.0025	CbGpPWpGaD
Amphetamine—Diarrhoea—Timolol—migraine	0.000155	0.00135	CcSEcCtD
Amphetamine—CYP2D6—head—migraine	0.000155	0.00299	CbGeAlD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—HTR3A—migraine	0.000155	0.00249	CbGpPWpGaD
Amphetamine—Decreased appetite—Topiramate—migraine	0.000154	0.00134	CcSEcCtD
Amphetamine—SLC6A2—Monoamine Transport—TNF—migraine	0.000154	0.00247	CbGpPWpGaD
Amphetamine—SLC6A3—NRF2 pathway—SLC6A4—migraine	0.000153	0.00247	CbGpPWpGaD
Amphetamine—Gastrointestinal disorder—Topiramate—migraine	0.000153	0.00133	CcSEcCtD
Amphetamine—Fatigue—Topiramate—migraine	0.000153	0.00133	CcSEcCtD
Amphetamine—SLC6A4—NRF2 pathway—TGFBR2—migraine	0.000152	0.00244	CbGpPWpGaD
Amphetamine—Constipation—Topiramate—migraine	0.000152	0.00132	CcSEcCtD
Amphetamine—Asthenia—Gabapentin—migraine	0.000151	0.00132	CcSEcCtD
Amphetamine—Nausea—Valproic Acid—migraine	0.000151	0.00132	CcSEcCtD
Amphetamine—Dizziness—Timolol—migraine	0.00015	0.0013	CcSEcCtD
Amphetamine—DRD2—G alpha (i) signalling events—HTR1D—migraine	0.000149	0.0024	CbGpPWpGaD
Amphetamine—CYP2D6—nervous system—migraine	0.000147	0.00284	CbGeAlD
Amphetamine—Gastrointestinal pain—Topiramate—migraine	0.000145	0.00126	CcSEcCtD
Amphetamine—Diarrhoea—Gabapentin—migraine	0.000144	0.00126	CcSEcCtD
Amphetamine—Vomiting—Timolol—migraine	0.000144	0.00125	CcSEcCtD
Amphetamine—Rash—Timolol—migraine	0.000143	0.00124	CcSEcCtD
Amphetamine—Dermatitis—Timolol—migraine	0.000143	0.00124	CcSEcCtD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—ATP1A2—migraine	0.000142	0.00228	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—ATP1A3—migraine	0.000142	0.00228	CbGpPWpGaD
Amphetamine—Headache—Timolol—migraine	0.000142	0.00124	CcSEcCtD
Amphetamine—CYP2D6—central nervous system—migraine	0.000141	0.00273	CbGeAlD
Amphetamine—Urticaria—Topiramate—migraine	0.000141	0.00123	CcSEcCtD
Amphetamine—Body temperature increased—Topiramate—migraine	0.00014	0.00122	CcSEcCtD
Amphetamine—Abdominal pain—Topiramate—migraine	0.00014	0.00122	CcSEcCtD
Amphetamine—Dizziness—Gabapentin—migraine	0.00014	0.00121	CcSEcCtD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000139	0.00223	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—BDNF—migraine	0.000139	0.00223	CbGpPWpGaD
Amphetamine—CYP2D6—cerebellum—migraine	0.000138	0.00267	CbGeAlD
Amphetamine—SLC6A4—Circadian rythm related genes—HTR7—migraine	0.000137	0.0022	CbGpPWpGaD
Amphetamine—SLC6A3—Monoamine Transport—TNF—migraine	0.000136	0.00219	CbGpPWpGaD
Amphetamine—Nausea—Timolol—migraine	0.000135	0.00117	CcSEcCtD
Amphetamine—Vomiting—Gabapentin—migraine	0.000134	0.00117	CcSEcCtD
Amphetamine—TAAR1—GPCR ligand binding—HTR2A—migraine	0.000134	0.00215	CbGpPWpGaD
Amphetamine—Rash—Gabapentin—migraine	0.000133	0.00116	CcSEcCtD
Amphetamine—Dermatitis—Gabapentin—migraine	0.000133	0.00116	CcSEcCtD
Amphetamine—TAAR1—GPCR downstream signaling—HTR1B—migraine	0.000133	0.00214	CbGpPWpGaD
Amphetamine—Headache—Gabapentin—migraine	0.000132	0.00115	CcSEcCtD
Amphetamine—Hypersensitivity—Topiramate—migraine	0.000131	0.00114	CcSEcCtD
Amphetamine—SLC6A2—NRF2 pathway—TGFBR2—migraine	0.000131	0.0021	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000129	0.00207	CbGpPWpGaD
Amphetamine—CYP2A6—NRF2 pathway—SLC6A4—migraine	0.000128	0.00206	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—HTR1A—migraine	0.000128	0.00206	CbGpPWpGaD
Amphetamine—Asthenia—Topiramate—migraine	0.000127	0.00111	CcSEcCtD
Amphetamine—TAAR1—GPCR downstream signaling—NPS—migraine	0.000126	0.00202	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—TAC1—migraine	0.000126	0.00202	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—ATP1A2—migraine	0.000126	0.00202	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—ATP1A3—migraine	0.000126	0.00202	CbGpPWpGaD
Amphetamine—Nausea—Gabapentin—migraine	0.000125	0.00109	CcSEcCtD
Amphetamine—DRD2—GPCR ligand binding—CALCRL—migraine	0.000125	0.002	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—RAMP1—migraine	0.000125	0.002	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—HTR2C—migraine	0.000124	0.00199	CbGpPWpGaD
Amphetamine—Diarrhoea—Topiramate—migraine	0.000122	0.00106	CcSEcCtD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—HTR3A—migraine	0.000121	0.00194	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—HTR1B—migraine	0.000121	0.00194	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—EDNRA—migraine	0.00012	0.00193	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000119	0.00191	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HTR1D—migraine	0.000118	0.00189	CbGpPWpGaD
Amphetamine—Dizziness—Topiramate—migraine	0.000117	0.00102	CcSEcCtD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—migraine	0.000117	0.00188	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—HTR1A—migraine	0.000116	0.00187	CbGpPWpGaD
Amphetamine—SLC6A3—NRF2 pathway—TGFBR2—migraine	0.000116	0.00186	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—CALCA—migraine	0.000116	0.00186	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—NPS—migraine	0.000114	0.00184	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—TAC1—migraine	0.000114	0.00184	CbGpPWpGaD
Amphetamine—Vomiting—Topiramate—migraine	0.000113	0.000982	CcSEcCtD
Amphetamine—CYP2D6—brain—migraine	0.000112	0.00217	CbGeAlD
Amphetamine—TAAR1—Signaling by GPCR—HTR2C—migraine	0.000112	0.0018	CbGpPWpGaD
Amphetamine—Rash—Topiramate—migraine	0.000112	0.000974	CcSEcCtD
Amphetamine—Dermatitis—Topiramate—migraine	0.000112	0.000973	CcSEcCtD
Amphetamine—Headache—Topiramate—migraine	0.000111	0.000968	CcSEcCtD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.00011	0.00178	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HTR2B—migraine	0.000109	0.00176	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—EDNRA—migraine	0.000109	0.00175	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—HTR7—migraine	0.000108	0.00174	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—HTR3A—migraine	0.000107	0.00172	CbGpPWpGaD
Amphetamine—Nausea—Topiramate—migraine	0.000105	0.000918	CcSEcCtD
Amphetamine—TAAR1—Signaling by GPCR—CALCA—migraine	0.000105	0.00169	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—HTR7—migraine	9.82e-05	0.00158	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—NPS—migraine	9.73e-05	0.00156	CbGpPWpGaD
Amphetamine—CYP2A6—NRF2 pathway—TGFBR2—migraine	9.67e-05	0.00155	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—LRP1—migraine	9.63e-05	0.00155	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—SLC6A4—migraine	9.54e-05	0.00153	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—HTR1B—migraine	9.06e-05	0.00146	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—HTR1D—migraine	9.05e-05	0.00145	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—HTR1A—migraine	8.72e-05	0.0014	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—HTR2B—migraine	8.41e-05	0.00135	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	8.4e-05	0.00135	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—HTR7—migraine	8.36e-05	0.00134	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	8.09e-05	0.0013	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	7.81e-05	0.00126	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	7.6e-05	0.00122	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—HTR2A—migraine	7.58e-05	0.00122	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—NOTCH4—migraine	7.39e-05	0.00119	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CACNA1A—migraine	7.31e-05	0.00117	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	7.2e-05	0.00116	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HTR1B—migraine	7.13e-05	0.00115	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—RAMP1—migraine	7.04e-05	0.00113	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CALCRL—migraine	7.04e-05	0.00113	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	6.93e-05	0.00111	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—HTR2A—migraine	6.88e-05	0.00111	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HTR1A—migraine	6.86e-05	0.0011	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—HTR7—migraine	6.84e-05	0.0011	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	6.83e-05	0.0011	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	6.83e-05	0.0011	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TAC1—migraine	6.76e-05	0.00109	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PGR—migraine	6.76e-05	0.00109	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—NPS—migraine	6.76e-05	0.00109	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	6.69e-05	0.00108	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HTR2C—migraine	6.63e-05	0.00106	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	6.51e-05	0.00105	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—EDNRA—migraine	6.45e-05	0.00104	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—RAMP1—migraine	6.39e-05	0.00103	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CALCRL—migraine	6.39e-05	0.00103	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—NOTCH3—migraine	6.28e-05	0.00101	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CALCA—migraine	6.2e-05	0.000997	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CACNA1A—migraine	6.18e-05	0.000994	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	5.86e-05	0.000942	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HTR7—migraine	5.8e-05	0.000933	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—HTR1B—migraine	5.48e-05	0.000881	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—HTR1A—migraine	5.28e-05	0.000848	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—TAC1—migraine	5.2e-05	0.000835	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—NPS—migraine	5.2e-05	0.000835	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—HTR1D—migraine	5.11e-05	0.000822	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—HTR2C—migraine	5.1e-05	0.000819	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—TNF—migraine	5.04e-05	0.00081	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TGFBR2—migraine	5e-05	0.000803	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—EDNRA—migraine	4.96e-05	0.000797	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	4.79e-05	0.00077	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CALCA—migraine	4.77e-05	0.000767	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—HTR2B—migraine	4.75e-05	0.000764	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HTR1D—migraine	4.64e-05	0.000746	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—HTR7—migraine	4.46e-05	0.000718	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HTR2B—migraine	4.32e-05	0.000694	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.11e-05	0.00066	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HTR2A—migraine	4.06e-05	0.000653	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CALCRL—migraine	3.78e-05	0.000607	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—RAMP1—migraine	3.78e-05	0.000607	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—ESR1—migraine	3.61e-05	0.00058	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CACNA1A—migraine	3.56e-05	0.000572	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—HTR2A—migraine	3.13e-05	0.000503	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—HTR1B—migraine	3.1e-05	0.000498	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—HTR1A—migraine	2.98e-05	0.000479	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—NPS—migraine	2.94e-05	0.000472	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—TAC1—migraine	2.94e-05	0.000472	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—HTR2C—migraine	2.88e-05	0.000463	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HTR1B—migraine	2.81e-05	0.000452	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—EDNRA—migraine	2.8e-05	0.00045	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR1D—migraine	2.74e-05	0.000441	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HTR1A—migraine	2.71e-05	0.000435	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CALCA—migraine	2.7e-05	0.000433	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—NPS—migraine	2.67e-05	0.000429	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—TAC1—migraine	2.67e-05	0.000429	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HTR2C—migraine	2.62e-05	0.00042	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR2B—migraine	2.55e-05	0.00041	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—EDNRA—migraine	2.54e-05	0.000409	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—HTR7—migraine	2.52e-05	0.000405	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CALCA—migraine	2.45e-05	0.000394	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—MTHFR—migraine	2.42e-05	0.000388	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HTR7—migraine	2.29e-05	0.000368	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—LRP1—migraine	2.25e-05	0.000361	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—MTHFR—migraine	2.05e-05	0.000329	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CACNA1A—migraine	2e-05	0.000321	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—HTR2A—migraine	1.77e-05	0.000284	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NOTCH4—migraine	1.72e-05	0.000277	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR1B—migraine	1.66e-05	0.000267	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HTR2A—migraine	1.6e-05	0.000258	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR1A—migraine	1.6e-05	0.000257	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NPS—migraine	1.58e-05	0.000253	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PGR—migraine	1.58e-05	0.000253	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TAC1—migraine	1.58e-05	0.000253	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR2C—migraine	1.55e-05	0.000248	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—EDNRA—migraine	1.5e-05	0.000242	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NOTCH3—migraine	1.46e-05	0.000235	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CALCA—migraine	1.45e-05	0.000233	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR7—migraine	1.35e-05	0.000218	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—MTHFR—migraine	1.18e-05	0.000189	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TGFBR2—migraine	1.17e-05	0.000187	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR2A—migraine	9.48e-06	0.000152	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ESR1—migraine	8.41e-06	0.000135	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—MTHFR—migraine	6.6e-06	0.000106	CbGpPWpGaD
